JD Health International Inc
HKEX:6618

Watchlist Manager
JD Health International Inc Logo
JD Health International Inc
HKEX:6618
Watchlist
Price: 29.45 HKD 0.51% Market Closed
Market Cap: 94.2B HKD
Have any thoughts about
JD Health International Inc?
Write Note

Net Margin
JD Health International Inc

4.8%
Current
-6%
Average
1.6%
Industry

Net Margin measures how much net income is generated as a percentage of revenues received. It helps investors assess if a company's management is generating enough profit from its sales and whether operating costs and overhead costs are being contained.

Net Margin
4.8%
=
Net Income
2.6B
/
Revenue
54.8B

Net Margin Across Competitors

Country CN
Market Cap 93.6B HKD
Net Margin
5%
Country US
Market Cap 2.4T USD
Net Margin
8%
Country ZA
Market Cap 875.3B Zac
Net Margin
48%
Country CN
Market Cap 204.8B USD
Net Margin
9%
Country CN
Market Cap 138.5B USD
Net Margin
29%
Country CN
Market Cap 965.6B HKD
Net Margin
7%
Country NL
Market Cap 95.1B EUR
Net Margin
121%
Country AR
Market Cap 88B USD
Net Margin
8%
Country UY
Market Cap 1.8T MXN
Net Margin
8%
Country US
Market Cap 71.3B USD
Net Margin
-2%
Country CN
Market Cap 409.9B HKD
Net Margin
3%
No Stocks Found

JD Health International Inc
Glance View

Market Cap
93.6B HKD
Industry
Retail

JD Health International Inc., a significant arm of the Chinese e-commerce giant JD.com, emerges as a leading force in the digital healthcare landscape. It operates by seamlessly blending technology with healthcare services, providing a multitude of solutions designed to cater to the diverse needs of its users. They have harnessed the power of the internet to offer online medical consultations, a service that connects patients with a network of licensed healthcare professionals. This innovative approach not only broadens access to medical advice and care but also disrupts traditional healthcare models by emphasizing convenience and accessibility. By utilizing advanced algorithms and AI technology, JD Health also offers personalized health management, positioning itself as a pivotal participant in the quest for enriched digital health experiences. The revenue model of JD Health is underpinned by its multifaceted ecosystem, primarily driven by the sale of pharmaceutical products, healthcare merchandise, and the provision of online medical services. They employ a B2C strategy that accounts for most of their sales, utilizing JD.com’s expansive logistics network to ensure swift and reliable delivery. Additionally, the company monetizes its platform by offering premium health-related content and services on a subscription basis, appealing to a broad audience eager to embrace new healthcare paradigms. As the digital transformation of healthcare accelerates, JD Health strategically positions itself to benefit from an expanding market, leveraging its technological expertise and comprehensive service offerings to make healthcare more accessible and efficient for its growing user base.

Intrinsic Value
35.2 HKD
Undervaluation 16%
Intrinsic Value
Price

See Also

Discover More
What is Net Margin?

Net Margin measures how much net income is generated as a percentage of revenues received. It helps investors assess if a company's management is generating enough profit from its sales and whether operating costs and overhead costs are being contained.

Net Margin
4.8%
=
Net Income
2.6B
/
Revenue
54.8B
What is the Net Margin of JD Health International Inc?

Based on JD Health International Inc's most recent financial statements, the company has Net Margin of 4.8%.